pharma · Asthma · Osteoarthritis · AMRX
Amneal Pharma Europe
Amneal Pharma Europe Ltd
Amneal Pharma Europe clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
400 Crossing Boulevard, Bridgewater, New Jersey 08807, US HQ
2002 Founded
7,179 Employees
Public company Type
AMRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 400 Crossing Boulevard, Bridgewater, New Jersey 08807, US
- Founded
- 2002
- Employees
- 7,179
- Programs
- 15
- Drugs
- 210
- Patents
- 32
Amneal Pharma Europe projects
0 ClinicalTrials.gov programs sponsored by Amneal Pharma Europe.
Amneal Pharma Europe has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Amneal Pharma Europe have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.